MARKET

BNTX

BNTX

BIONTECH
NASDAQ

Real-time Quotes | Nasdaq Last Sale

67.00
+0.22
+0.33%
After Hours: 67.35 +0.35 +0.52% 19:59 09/18 EDT
OPEN
68.01
PREV CLOSE
66.78
HIGH
68.44
LOW
65.17
VOLUME
2.61M
TURNOVER
--
52 WEEK HIGH
105.00
52 WEEK LOW
12.53
MARKET CAP
15.96B
P/E (TTM)
-70.3117
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile

Analyst Price Target

The average BNTX stock price target is 80.04 with a high estimate of 99.95 and a low estimate of 51.97.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About BNTX
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of BioNTech SE - ADR stock information, including NASDAQ:BNTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BNTX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BNTX stock methods without spending real money on the virtual paper trading platform.